|
Real-time Estimate
Cboe BZX
18:12:20 24/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.14 USD | +1.68% |
|
+3.87% | +132.05% |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| 07-30 | Barrington Raises Price Target on Anika Therapeutics to $21 From $17, Keeps Outperform Rating | MT |
| Market Cap | 291M 250M 234M 214M 401M 27.89B 407M 2.76B 1.08B 14.01B 1.09B 1.07B 46.34B | P/E 2026 * |
-2,178x | P/E 2027 * | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 291M 250M 234M 214M 401M 27.89B 407M 2.76B 1.08B 14.01B 1.09B 1.07B 46.34B | EV / Sales 2026 * |
2.38x | EV / Sales 2027 * | 2.27x |
| Free-Float |
79.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Anika Therapeutics, Inc.
| 1 day | +1.68% | ||
| 1 week | +3.87% | ||
| Current month | +15.66% | ||
| 1 month | +49.16% | ||
| 3 months | +49.76% | ||
| 6 months | +105.53% | ||
| Current year | +132.05% |
| 1 week | 21.01 |  | 22.52 |
| 1 month | 14.88 | | 22.88 |
| Current year | 9.01 | | 22.88 |
| 1 year | 8.37 | | 22.88 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 40 | 01/02/2026 |
Dawn J. Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2023 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 14/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 61 | 01/02/2026 |
John Henneman
CHM | Chairman | 64 | 24/02/2024 |
Stephen Richard
BRD | Director/Board Member | 63 | 03/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/08/26 | Buy | Director | 1,000 | 0.0075% | ||
| 01/02/26 | Other | Chief Executive Officer | 440,609 | 3.0553% | ||
| 20/06/25 | Free | Director | 14,164 | 0.0967% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +3.87% | +144.25% | +19.76% | 291M | |
| +0.45% | +6.04% | -11.25% | +12.81% | 202B | |
| +0.11% | +3.57% | +1.94% | +15.75% | 119B | |
| +0.44% | +2.46% | +11.06% | +79.11% | 60.69B | |
| 0.00% | -5.70% | +29.16% | +55.35% | 52.38B | |
| +0.15% | +5.83% | -1.00% | -30.43% | 52.3B | |
| -0.40% | +3.64% | +21.11% | -8.90% | 34.85B | |
| +1.05% | +0.06% | - | - | 30.06B | |
| -0.51% | +1.75% | +42.66% | -9.97% | 24.85B | |
| +1.03% | -0.94% | -1.24% | +24.84% | 23.84B | |
| Average | +0.39% | +0.38% | +26.30% | +17.59% | 60.06B | |
| Weighted average by Cap. | +0.26% | +1.90% | +3.36% | +18.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 105M 97.97M 89.68M 168M 11.7B 171M 1.16B 451M 5.88B 459M 449M 19.43B | 129M 110M 103M 94.32M 177M 12.3B 179M 1.22B 475M 6.18B 483M 472M 20.44B |
| Net income | -67.5K -57.82K -54.1K -49.52K -92.94K -6.46M -94.17K -639K -249K -3.24M -253K -248K -10.73M | 6.42M 5.5M 5.15M 4.71M 8.84M 615M 8.96M 60.83M 23.72M 309M 24.12M 23.59M 1.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/08/26 | $22.27 | +2.25% | 29,136 |
| 21/08/26 | $21.78 | +2.06% | 340,432 |
| 20/08/26 | $21.34 | +0.38% | 89,336 |
| 19/08/26 | $21.26 | -1.44% | 80,206 |
| 18/08/26 | $21.57 | +0.47% | 87,032 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
